002788SZSE

Independent Director 2025 Annual Work Report (Ye Shaoqin)

Luyan Pharmaceutical Co., Ltd.··5p

✨ AI Summary

This report details the 2025 work of Independent Director Ye Shaoqin. The director attended 4 board meetings and 2 special committee meetings (Audit and Nomination). Key activities included ensuring compliance with regulations, protecting minority shareholder rights, and engaging in on-site investigations. The director plans to enhance shareholder communication and improve corporate governance in the future.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openaiSign In to Upgrade

I. Situation of the Board of Directors and Shareholders

In 2025, the company held 4 board meetings and 1 annual shareholders' meeting. The details are as follows:

Meeting TypeNumber of MeetingsNumber of EventsNumber of VotesVoting Situation (For)Voting Situation (Against)
Board Meetings44040

II. Participation in Special Committees

In 2025, the company held 1 meeting of the audit committee and 1 meeting of the nomination committee. The details are as follows:

Special CommitteeNumber of Meetings HeldNumber of Meetings AttendedNumber of VotesVoting Situation (For)Voting Situation (Against)
Audit Committee44040
Nomination Committee11010

III. Annual Report on Key Issues

The company has established a system for the annual meeting of shareholders, ensuring compliance with relevant regulations. The independent director has actively participated in discussions and decision-making processes, contributing to the company's governance.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.

Notes & Comments

Sign in to leave a comment or private note.

Loading…

Independent Director 2025 Annual Work Report (Ye Shaoqin) — Luyan Pharmaceutical Co., Ltd. | SZSE Releases